Your browser doesn't support javascript.
loading
An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease.
Mastboim, Niv Samuel; Angel, Alon; Shaham, Oded; Ber, Tahel Ilan; Navon, Roy; Simon, Einav; Rosenberg, Michal; Israeli, Yael; Hainrichson, Mary; Avni, Noa; Reiner, Eran; Feigin, Paul; Oved, Kfir; Tadmor, Boaz; Singer, Pierre; Kagan, Ilya; Lev, Shaul; Diker, Dror; Jarjou'I, Amir; Kurd, Ramzi; Ben-Chetrit, Eli; Danziger, Guy; Tegethoff, Sina A; Papan, Cihan; Motov, Sergey; Shapira, Ma'anit; Stein, Michal; Gottlieb, Tanya M; Eden, Eran; Klein, Adi.
Afiliação
  • Mastboim NS; MeMed, Tirat Carmel, Israel.
  • Angel A; MeMed, Tirat Carmel, Israel.
  • Shaham O; MeMed, Tirat Carmel, Israel.
  • Ber TI; MeMed, Tirat Carmel, Israel.
  • Navon R; MeMed, Tirat Carmel, Israel.
  • Simon E; MeMed, Tirat Carmel, Israel.
  • Rosenberg M; MeMed, Tirat Carmel, Israel.
  • Israeli Y; MeMed, Tirat Carmel, Israel.
  • Hainrichson M; MeMed, Tirat Carmel, Israel.
  • Avni N; MeMed, Tirat Carmel, Israel.
  • Reiner E; MeMed, Tirat Carmel, Israel.
  • Feigin P; Technion-Israel Institute of Technology, Israel.
  • Oved K; MeMed, Tirat Carmel, Israel; Canopy Immuno-therapeutics, Israel.
  • Tadmor B; Holon Institute of Technology, Israel.
  • Singer P; Rabin Medical Center, Israel.
  • Kagan I; Rabin Medical Center, Israel.
  • Lev S; Rabin Medical Center, Israel.
  • Diker D; Rabin Medical Center, Israel.
  • Jarjou'I A; Shaare Zedek Medical Center, Hebrew University School of Medicine, Israel.
  • Kurd R; Shaare Zedek Medical Center, Hebrew University School of Medicine, Israel.
  • Ben-Chetrit E; Shaare Zedek Medical Center, Hebrew University School of Medicine, Israel.
  • Danziger G; Saarland University Hospital, Germany.
  • Tegethoff SA; Saarland University Hospital, Germany.
  • Papan C; Saarland University Hospital, Germany.
  • Motov S; Maimonides Medical Center, US.
  • Shapira M; Technion-Israel Institute of Technology, Israel; Hillel Yaffe Medical Center, Israel.
  • Stein M; Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Israel; Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel.
  • Gottlieb TM; MeMed, Tirat Carmel, Israel. Electronic address: tanya.gottlieb@me-med.com.
  • Eden E; MeMed, Tirat Carmel, Israel.
  • Klein A; Technion-Israel Institute of Technology, Israel; Hillel Yaffe Medical Center, Israel.
Cytokine ; 169: 156246, 2023 09.
Article em En | MEDLINE | ID: mdl-37327532
ABSTRACT
COVID-19 patients are oftentimes over- or under-treated due to a deficit in predictive management tools. This study reports derivation of an algorithm that integrates the host levels of TRAIL, IP-10, and CRP into a single numeric score that is an early indicator of severe outcome for COVID-19 patients and can identify patients at-risk to deteriorate. 394 COVID-19 patients were eligible; 29% meeting a severe outcome (intensive care unit admission/non-invasive or invasive ventilation/death). The score's area under the receiver operating characteristic curve (AUC) was 0.86, superior to IL-6 (AUC 0.77; p = 0.033) and CRP (AUC 0.78; p < 0.001). Likelihood of severe outcome increased significantly (p < 0.001) with higher scores. The score differentiated severe patients who further deteriorated from those who improved (p = 0.004) and projected 14-day survival probabilities (p < 0.001). The score accurately predicted COVID-19 patients at-risk for severe outcome, and therefore has potential to facilitate timely care escalation and de-escalation and appropriate resource allocation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cytokine Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cytokine Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel